MEDEZE Share Price Performance
฿7.20
-4.00 (-35.71%)
Price ฿7.20
Share Price฿7.20
MEDEZE Community Narratives
There are no narratives available yet.
Recent MEDEZE News & Updates
No updates
Medeze Group Public Company Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.33
- Gross Margin
- 79.53%
- Net Profit Margin
- 39.16%
- Debt/Equity Ratio
- 0%
Medeze Group Public Company Limited Competitors
About MEDEZE
- Founded
- 2010
- Employees
- n/a
- CEO
- WebsiteView website
Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells; and research, develops, and collects data on all types of human cellular activities and medical laboratory test. In addition, the company sells dietary supplements, cosmetics, and dermo cosmetics. The company was founded in 2010 and is based in Nakhon Pathom, Thailand.
Thai Market Performance
- 7 Days: 0.1%
- 3 Months: 1.6%
- 1 Year: -7.6%
- Year to Date: -11.3%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. Unfortunately though, the market is down 7.6% over the past year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading